These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29568778)

  • 1. Integration of Routine Parameters of Glycemic Variability in a Simple Screening Method for Partial Remission in Children with Type 1 Diabetes.
    Nielens N; Pollé O; Robert A; Lysy PA
    J Diabetes Res; 2018; 2018():5936360. PubMed ID: 29568778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes.
    Max Andersen ML; Hougaard P; Pörksen S; Nielsen LB; Fredheim S; Svensson J; Thomsen J; Vikre-Jørgensen J; Hertel T; Petersen JS; Hansen L; Mortensen HB
    Pediatr Diabetes; 2014 Nov; 15(7):469-76. PubMed ID: 25287319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New definition for the partial remission period in children and adolescents with type 1 diabetes.
    Mortensen HB; Hougaard P; Swift P; Hansen L; Holl RW; Hoey H; Bjoerndalen H; de Beaufort C; Chiarelli F; Danne T; Schoenle EJ; Aman J;
    Diabetes Care; 2009 Aug; 32(8):1384-90. PubMed ID: 19435955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission.
    Lundberg RL; Marino KR; Jasrotia A; Maranda LS; Barton BA; Alonso LC; Nwosu BU
    J Pediatr Endocrinol Metab; 2017 Aug; 30(8):823-830. PubMed ID: 28753540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in insulin sensitivity in the partial remission phase of childhood type 1 diabetes; a longitudinal cohort study.
    Mørk FCB; Madsen JOB; Jensen AK; Hall GV; Pilgaard KA; Pociot F; Johannesen J
    Diabet Med; 2022 Feb; 39(2):e14702. PubMed ID: 34564895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria.
    Nagl K; Hermann JM; Plamper M; Schröder C; Dost A; Kordonouri O; Rami-Merhar B; Holl RW
    Pediatr Diabetes; 2017 Sep; 18(6):428-434. PubMed ID: 27416952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial remission in type 1 diabetes and associated factors: Analysis based on the insulin dose-adjusted hemoglobin A1c in children and adolescents from a regional diabetes center, Auckland, New Zealand.
    Chiavaroli V; Derraik JGB; Jalaludin MY; Albert BB; Ramkumar S; Cutfield WS; Hofman PL; Jefferies CA
    Pediatr Diabetes; 2019 Nov; 20(7):892-900. PubMed ID: 31237756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.
    Pinckney A; Rigby MR; Keyes-Elstein L; Soppe CL; Nepom GT; Ehlers MR
    Clin Ther; 2016 Jun; 38(6):1327-1339. PubMed ID: 27209482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study.
    Boutsen L; Costenoble E; Pollé O; Erdem K; Bugli C; Lysy PA
    Ther Adv Endocrinol Metab; 2023; 14():20420188221145550. PubMed ID: 36699944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.
    Marino KR; Lundberg RL; Jasrotia A; Maranda LS; Thompson MJ; Barton BA; Alonso LC; Nwosu BU
    PLoS One; 2017; 12(5):e0176860. PubMed ID: 28459844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial remission in children and adolescents with type 1 diabetes: an analysis based on the insulin dose-adjusted hemoglobin A1c.
    Cimbek EA; Bozkır A; Usta D; Beyhun NE; Ökten A; Karagüzel G
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1311-1317. PubMed ID: 34271601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial Clinical Remission of Type 1 Diabetes: The Need for an Integrated Functional Definition Based on Insulin-Dose Adjusted A1c and Insulin Sensitivity Score.
    Nwosu BU
    Front Endocrinol (Lausanne); 2022; 13():884219. PubMed ID: 35592786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Young children (<5 yr) and adolescents (>12 yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor.
    Bowden SA; Duck MM; Hoffman RP
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):197-201. PubMed ID: 18547233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and determinants of partial remission in children with type 1 diabetes using the insulin-dose-adjusted A1C definition.
    Pecheur A; Barrea T; Vandooren V; Beauloye V; Robert A; Lysy PA
    J Diabetes Res; 2014; 2014():851378. PubMed ID: 25254220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved clinical model to predict stimulated C-peptide in children with recent-onset type 1 diabetes.
    Buchanan K; Mehdi AM; Hughes I; Cotterill A; Le Cao KA; Thomas R; Harris M
    Pediatr Diabetes; 2019 Mar; 20(2):166-171. PubMed ID: 30556344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.
    Böber E; Dündar B; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2001 Apr; 14(4):435-41. PubMed ID: 11327378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Beta Cell Function Is Predictive of Diabetes Remission After Bariatric Surgery.
    Souteiro P; Belo S; Neves JS; Magalhães D; Silva RB; Oliveira SC; Costa MM; Saavedra A; Oliveira J; Cunha F; Lau E; Esteves C; Freitas P; Varela A; Queirós J; Carvalho D
    Obes Surg; 2017 Feb; 27(2):288-294. PubMed ID: 27435450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Metabolic Outcomes in Children Diagnosed with Type 1 Diabetes Through Research Screening (Diabetes Autoimmunity Study in the Young [DAISY]) Versus in the Community.
    Chan CL; Taki I; Dong F; Hoffman M; Norris JM; Klingensmith G; Rewers MJ; Steck AK
    Diabetes Technol Ther; 2015 Sep; 17(9):649-56. PubMed ID: 26317880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone turnover markers during the remission phase in children and adolescents with type 1 diabetes.
    Madsen JOB; Herskin CW; Zerahn B; Jensen AK; Jørgensen NR; Olsen BS; Svensson J; Pociot F; Johannesen J
    Pediatr Diabetes; 2020 Mar; 21(2):366-376. PubMed ID: 31840392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.
    Hao W; Gitelman S; DiMeglio LA; Boulware D; Greenbaum CJ;
    Diabetes Care; 2016 Oct; 39(10):1664-70. PubMed ID: 27422577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.